MAPT and Parkinson disease: Inspired by these findings, Bagchi et al. radiolabeled SIL23 with iodine-125 and evaluated its selectivity profile against Aβ1–42 and tau fibrils as well as its binding properties at LBs and LNs present in human PD brains.